2022
DOI: 10.21608/bfsa.2022.135068.1355
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Safety and Resistance Associated Variants of Sofosbuvir/Daclatasvir among Egyptian Patients with Hepatitis C Virus: A Prospective Study

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles